Oramed Pharmaceuticals ($ORMP) Insider Trading & Smart Money Activity

Oramed Pharmaceuticals Inc. · Latest filing Oct 1, 2026

Oramed Pharmaceuticals Inc. ($ORMP) has 2 insider trades on file. In the last 12 months on the open market, no insider bought and 2 insiders sold ($225.53K), net -$225.53K.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
2
Net insider $ (12 mo)
-$225.53K
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

ORMP insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 2 · $225.53K 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All ORMP insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Hexter JoshuaCOO & CBO Sell (Open-market sale) 10b5-1 30K sh $135.33K —
Insider Gabay AvrahamChief Financial Officer Sell (Open-market sale) 10b5-1 20K sh $90.20K —

1W / 1M / 6M = how ORMP moved from the trade or filing date.

Insider trading in ORMP: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Hexter Joshua COO & CBO 1 -$135.33K Oct 1, 2026
Gabay Avraham Chief Financial Officer 1 -$90.20K Oct 1, 2026

Frequently asked questions

Are ORMP insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 2 insiders made 2 open-market sales worth $225.53K, a net -$225.53K.

What is the latest insider trade in ORMP?

Hexter Joshua, COO & CBO filed a sell (open-market sale) of 30K sh worth $135.33K on Oct 1, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text

SMS Terms

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Full terms and conditions